Trading Signals: BLUE Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. May. 13, 2022)(BLUEBIRD BIO INC)
| Market is closed on Tue. Jun. 14, 2022 | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 0% (three month average) | | RSI | | | Latest Price | $(0%) | | Stocks Behave Similarly | Similar Stock List | | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support BLUE advance at 0% a week (0% probability)
(0%) (0%) (0%) (0%) (0%) | | Factors Impacting BLUE price | BLUE will advance at least -0% in a week (0% probabilities).
(0%) (0%) (0%) (0%) (0%) | | | | | | | | Relative Volatility | | | | | | Market Trend Strength | 0% (StdDev 0%) | | Hourly BBV | 0 () | | Intraday Trend | NAN% | | | | | |
|
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in the development of potential gene therapies for severe genetic diseases and cancer. Its integrated product platform includes gene therapy, cancer immunotherapy, and gene editing. Its product pipeline includes Lenti-D, LentiGlobin, BCL11a shRNA, bb2121, and bb21217. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Cambridge, MA. |